Zyme Communications

Zyme Communications company information, Employees & Contact Information

Zyme Communications provides strategic and specialist communications services for the life science sector. Based in Cambridge and Manchester in the UK, and with clients across Europe, the USA, and Asia. Zyme is focused on supporting companies to raise their profile and generate interest from commercial leads, investors, prospective employees, and partners. With an international network of life science trade media contacts and a strong technical understanding, Zyme is committed to delivering value and results from objectives-led communications. Founded in 2010, Zyme has experience of working with over 100 leading life science organisations.

Company Details

Employees
14
Founded
-
Address
Cambridge Innovation Park, Waterbeach,cambridgeshire Cb25 9pb,united Kingdom
Industry
Public Relations And Communications Services
NAICS
Public Relations Agencies
HQ
Waterbeach, Cambridgeshire
Looking for a particular Zyme Communications employee's phone or email?

Zyme Communications Questions

News

ProImmune Expands into New 18,000 sq ft Global Headquarters Enabling Major Expansion in Immunology and Life Science Innovation - Business Wire

ProImmune Expands into New 18,000 sq ft Global Headquarters Enabling Major Expansion in Immunology and Life Science Innovation Business Wire

Zyme Communications celebrates 15 years of providing specialist support for the life science sector - Cambridge Network

Zyme Communications celebrates 15 years of providing specialist support for the life science sector Cambridge Network

Tecan Introduces Veya: Bringing Digital, Scalable Automation to Labs Worldwide - Business Wire

Tecan Introduces Veya: Bringing Digital, Scalable Automation to Labs Worldwide Business Wire

Evonetix announces early access program for semiconductor synthesized DNA - Evonetix

Evonetix announces early access program for semiconductor synthesized DNA Evonetix

FUJIFILM Irvine Scientific Sells its Medical Media Business to Astorg - Business Wire

FUJIFILM Irvine Scientific Sells its Medical Media Business to Astorg Business Wire

Evonetix granted patent for technology enabling thermally-controlled DNA synthesis - Evonetix

Evonetix granted patent for technology enabling thermally-controlled DNA synthesis Evonetix

Evonetix granted patent for DNA data storage and retrieval method - Evonetix

Evonetix granted patent for DNA data storage and retrieval method Evonetix

Cyclana Bio Raises £5M to Advance Drug Discovery for Endometriosis - Business Wire

Cyclana Bio Raises £5M to Advance Drug Discovery for Endometriosis Business Wire

Evonetix appoints Andrew Diston as Chief Executive Officer - Evonetix

Evonetix appoints Andrew Diston as Chief Executive Officer Evonetix

Mosaic Therapeutics Appoints Thomas Fuchs as CEO - Business Wire

Mosaic Therapeutics Appoints Thomas Fuchs as CEO Business Wire

FairJourney Biologics Appoints Dr. Werner Lanthaler as Chief Executive Officer - Business Wire

FairJourney Biologics Appoints Dr. Werner Lanthaler as Chief Executive Officer Business Wire

Sapio Sciences Appoints Gordon McCall as Chief Operating Officer to Drive Global Operational Excellence - Business Wire

Sapio Sciences Appoints Gordon McCall as Chief Operating Officer to Drive Global Operational Excellence Business Wire

IBL International collaborates with Grifols on advanced biomarker panels - Business Wire

IBL International collaborates with Grifols on advanced biomarker panels Business Wire

Metrion Biosciences appoints Lee Patterson as CEO - Business Wire

Metrion Biosciences appoints Lee Patterson as CEO Business Wire

Enhanced Genomics Extends Series A Funding to USD $19 Million to Drive Development of Therapeutics Pipeline - Business Wire

Enhanced Genomics Extends Series A Funding to USD $19 Million to Drive Development of Therapeutics Pipeline Business Wire

CN Bio and Pharmaron Establish Long-Term Strategic Partnership to Develop OOC Technologies on a Global R&D Platform - Business Wire

CN Bio and Pharmaron Establish Long-Term Strategic Partnership to Develop OOC Technologies on a Global R&D Platform Business Wire

Calluna Pharma Successfully Completes Phase 1 Clinical Study of CAL101, a First-in-Class Therapeutic for Fibrotic and Fibro-Inflammatory Indications - Business Wire

Calluna Pharma Successfully Completes Phase 1 Clinical Study of CAL101, a First-in-Class Therapeutic for Fibrotic and Fibro-Inflammatory Indications Business Wire

Axol Bioscience Acquires Phenocell to Advance Human Disease Models - Business Wire

Axol Bioscience Acquires Phenocell to Advance Human Disease Models Business Wire

DefiniGEN and Atelerix Collaborate to Ship In Vitro Cell Models Internationally Without the Need for Freezing or Cryopreservation - Business Wire

DefiniGEN and Atelerix Collaborate to Ship In Vitro Cell Models Internationally Without the Need for Freezing or Cryopreservation Business Wire

Astrea Bioseparations Acquires Delta Precision Ltd, a Leading Manufacturer of Chromatography Columns for Biomanufacturing - Business Wire

Astrea Bioseparations Acquires Delta Precision Ltd, a Leading Manufacturer of Chromatography Columns for Biomanufacturing Business Wire

Pheno Therapeutics Announces Worldwide License From UCB to a Novel Program for Neurodegenerative Disease - Business Wire

Pheno Therapeutics Announces Worldwide License From UCB to a Novel Program for Neurodegenerative Disease Business Wire

Evonetix raises $30 million USD (£23 million GBP) - Evonetix

Evonetix raises $30 million USD (£23 million GBP) Evonetix

Evonetix demonstrates novel enzymatic DNA synthesis method - Evonetix

Evonetix demonstrates novel enzymatic DNA synthesis method Evonetix

TTP plc Selected for Technology Advisory Partnership With Cancer Research UK - Business Wire

TTP plc Selected for Technology Advisory Partnership With Cancer Research UK Business Wire

Evonetix appoints Dr Michael Daniels as Head of Product Management - Evonetix

Evonetix appoints Dr Michael Daniels as Head of Product Management Evonetix

Sphere Fluidics secures £30 million Series B investment led by Sofinnova Partners and Redmile Group - UK Tech Investment News

Sphere Fluidics secures £30 million Series B investment led by Sofinnova Partners and Redmile Group UK Tech Investment News

Mogrify secures £830k grant funding from SBRI Healthcare - UK Tech Investment News

Mogrify secures £830k grant funding from SBRI Healthcare UK Tech Investment News

Top Zyme Communications Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant